Skip to main content
logo
Green Lifescience Co., Ltd. (KOSDAQ:114450)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,335.00
+75.00 (3.32%)
At close: Aug 18, 2026

Green Lifescience Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
3,011110.131,562-16,358-3,526-3,136
Depreciation & Amortization
773.4789.88768.542,4762,7692,565
Loss (Gain) From Sale of Assets
00---1.392.24
Asset Writedown & Restructuring Costs
1,3571,357-12,095--
Loss (Gain) From Sale of Investments
-1,670-1,148144.81-43.71-694.8-416.74
Provision & Write-off of Bad Debts
-67.7-67.735.349.5-34.8517.15
Other Operating Activities
-944.94246.91-1,460693.591,364-369.63
Change in Accounts Receivable
-6,522-1,944-3,500984.56871.71-1,716
Change in Inventory
-3,344-4,4562,187460.55-782.871,270
Change in Accounts Payable
5,5435,4611,409-84.25-3,2761,277
Change in Unearned Revenue
-42.5-41.2112.71-34-
Change in Other Net Operating Assets
-31.6656.08-634.3697.1-1,2741,118
Operating Cash Flow
-1,939363.85525.49370.02-4,552611.38
Operating Cash Flow Growth
--30.76%42.02%---67.86%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-894.04-859.51-780.62-495.69-1,478-3,444
Sale of Property, Plant & Equipment
----1.52.1
Sale (Purchase) of Intangibles
-606.52-300.71-60.3-10.2--
Investment in Securities
2,0241,2054,1437,7916,4892,948
Other Investing Activities
4.0110.36-22.21230.7544.54-108.34
Investing Cash Flow
527.4454.793,2807,5165,057-602

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-1,700-15,7539,55210,128
Long-Term Debt Issued
-101.06----
Total Debt Issued
1,8011,801-15,7539,55210,128
Short-Term Debt Repaid
----17,441-10,418-8,911
Long-Term Debt Repaid
--180.79-189.63-221.77-205.29-256.23
Total Debt Repaid
-1,870-180.79-189.63-17,663-10,623-9,167
Net Debt Issued (Repaid)
-69.081,620-189.63-1,910-1,071961.34
Issuance of Common Stock
2,4152,415----
Repurchase of Common Stock
---1,657-2,366--
Other Financing Activities
-102.29-127.29-82-30.840-0
Financing Cash Flow
2,2433,908-1,928-4,307-1,071961.34

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
537.5912.82843.02-45.14-7.6915.17
Net Cash Flow
1,3704,3392,7203,533-573.99985.91

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2,833-495.66-255.13-125.67-6,030-2,832
Free Cash Flow Growth
------
Free Cash Flow Margin
-5.55%-1.23%-1.03%-0.56%-16.52%-11.18%
Free Cash Flow Per Share
-146.14-25.82-13.26-6.30-301.49-141.61
Levered Free Cash Flow
-4,064-866.81-848.11812.18-4,933-1,743
Unlevered Free Cash Flow
-3,921-715.46-699.32962.45-4,862-1,730

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
275.93209.1234.3226.53163.8418.33
Cash Income Tax Paid
--6.95-55.8-69.5883.73-0.45
Change in Working Capital
-4,397-924.05-525.361,458-4,4281,949